ARTICLE | Clinical News
Neotrofin leteprinim (AIT-082): Began Phase II trials
October 1, 2001 7:00 AM UTC
NeoTherapeutics Inc. (NEOT), Irvine, Calif. Product: Neotrofin leteprinim (AIT-082) Business: Neurological Therapeutic category: Growth factor, Nerve regeneration Target: Neurotrophic factors Descript...